Characterization of purine‐rich element binding protein B as a novel biomarker in acute myelogenous leukemia prognostication

RJ Kelm Jr, GS Lamba, JE Levis… - Journal of cellular …, 2018 - Wiley Online Library
Acute myelogenous leukemia (AML) is an aggressive hematologic cancer characterized by
infiltration of proliferative, clonal, abnormally differentiated cells of myeloid lineage in the …
被引用次数：12 相关文章

Characterization of purine-rich element binding protein B as a novel biomarker in acute myelogenous leukemia prognostication.

RJ Kelm Jr, GS Lamba, JE Levis… - Journal of Cellular …, 2017 - europepmc.org
Acute myelogenous leukemia (AML) is an aggressive hematologic cancer characterized by
infiltration of proliferative, clonal, abnormally differentiated cells of myeloid lineage in the …

Characterization of purine-rich element binding protein B as a novel biomarker in acute myelogenous leukemia prognostication

RJ Kelm Jr, GS Lamba, JE Levis… - Journal of cellular …, 2018 - pubmed.ncbi.nlm.nih.gov
Acute myelogenous leukemia (AML) is an aggressive hematologic cancer characterized by
infiltration of proliferative, clonal, abnormally differentiated cells of myeloid lineage in the …